Quantcast
Potential Drug Therapy For Kidney Stones Identified In Mouse

Potential Drug Therapy For Kidney Stones Identified In Mouse Study

Caroline Arbanas, Washington University in St. Louis Anyone who has suffered from kidney stones is keenly aware of the lack of drugs to treat the condition, which often causes excruciating pain. A new mouse study, however, suggests that a...

Latest Mood stabilizers Stories

2014-07-28 08:30:11

An Innovative Approach That Puts Clinicians in Charge MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that it has launched the Upsher-Smith Galaxy(TM), a new and growing suite of antiepileptic drugs (AEDs) that offers people with epilepsy consistent, affordable and accessible therapies. The current Upsher-Smith Galaxy(TM) Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three...

2014-07-25 23:01:34

On July 21, the FDA informed that one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health Packaging (AHP), are recalled due to mislabeled packaging. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 25, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Ibuprofen and Oxcarbazepine...

2014-07-14 08:27:51

Authorized Generic Topiramate Extended-Release Capsules Available Nationwide MAPLE GROVE, Minn., July 14, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the launch of Topiramate Extended-Release Capsules, the authorized generic of the recently Food and Drug Administration (FDA) approved Qudexy(TM) XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK)...

2014-07-11 08:24:53

MISSISSAUGA, ON, July 11, 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today announced that Health Canada approved APTIOM(TM) (eslicarbazepine acetate) for use as a once-daily adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy who are not satisfactorily controlled with conventional therapy. APTIOM(TM) is not indicated for use in patients under 18 years of age. Epilepsy is one of the most common neurological disorders and...

2014-06-30 08:31:21

First Branded Product in CNS Portfolio Now Available MAPLE GROVE, Minn., June 30, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that Qudexy(TM) XR (topiramate) extended-release capsules is now available to patients in the United States. Qudexy(TM) XR is a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile. It was approved by the U.S. Food and Drug Administration in March 2014...

2014-06-29 23:00:49

RnRMarketResearch.com adds latest report on “Global and Chinese Lithium Sulfate (CAS 10377-48-7) Industry, 2009-2019 Market Research Report” to its store. Place a direct purchase order at http://www.rnrmarketresearch.com/contacts/purchase?rname=191509. Dallas, TX (PRWEB) June 29, 2014 Delivery of the Report will take 2-3 working days once order is placed. This report is a professional and in-depth market survey on Global and Chinese Lithium Sulfate (CAS 10377-48-7) industry. The...

2014-06-17 08:26:35

Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from Upsher-Smith Laboratories, Inc.'s, Phase 3 study of USL255, Qudexy(TM) XR (topiramate) extended-release capsules, a proprietary, once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile, were published in the June issue of Epilepsia, a leading, authoritative...

2014-04-25 08:27:40

WOODCLIFF LAKE, N.J., April 25, 2014 /PRNewswire/ -- Eisai Inc. announced today that six abstracts highlighting data analyses for FYCOMPA(TM) (perampanel) will be presented at the 66(th) annual American Academy of Neurology (AAN) meeting, taking place in Philadelphia, PA from April 26( )- May 3. http://photos.prnewswire.com/prnvar/20120413/MM87168LOGO "Eisai and its epilepsy franchise are committed to expanding its knowledge of current products and developing new medications for the...

2014-04-24 23:17:14

Flood Law Group announced today that they are available to investigate the claims of parents of children who suffer from birth defects that are possibly linked to the prescription drug Depakote. Flood Law Group always conducts a thorough investigation of a claim before taking on a case. Washington, D.C. (PRWEB) April 24, 2014 Flood Law Group today announced that they are now available to investigate the claims of parents of children who suffered from birth defects possibly as a result of...

2014-04-21 12:27:11

Upsher-Smith-sponsored data to include the first presentation of pooled Phase 1 data on the adverse event profile of USL255 (Qudexy(TM) XR (topiramate) extended-release capsules) MAPLE GROVE, Minn., April 21, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), will highlight new pooled phase 1 data from studies in healthy adults comparing the adverse event profile of USL255 (Qudexy(TM) XR) with immediate-release topiramate in a poster presentation at the 66(th) Annual Meeting...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related